WDR61 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.813800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.032400E-01
Normal-vs-Stage2
7.610600E-01
Normal-vs-Stage3
5.470000E-01
Normal-vs-Stage4
6.644800E-01
Stage1-vs-Stage2
3.775600E-02
Stage1-vs-Stage3
1.765370E-01
Stage1-vs-Stage4
2.235000E-01
Stage2-vs-Stage3
4.602200E-01
Stage2-vs-Stage4
8.664800E-01
Stage3-vs-Stage4
7.292800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.407600E-01
Normal-vs-AfricanAmerican
9.545600E-01
Normal-vs-Asian
3.472600E-01
Caucasian-vs-AfricanAmerican
9.734200E-01
Caucasian-vs-Asian
8.926000E-02
AfricanAmerican-vs-Asian
2.517200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.068400E-01
Normal-vs-Female
9.820800E-01
Male-vs-Female
3.900000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.453600E-01
Normal-vs-Age(41-60Yrs)
9.990000E-01
Normal-vs-Age(61-80Yrs)
7.714600E-01
Normal-vs-Age(81-100Yrs)
8.422600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.815400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.298400E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.572550E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.257000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.872400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.774800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.908600E-01
Normal-vs-Daily Drinker
3.959200E-01
Normal-vs-Weekly Drinker
7.959200E-01
Normal-vs-Occasional Drinker
9.081400E-01
Normal-vs-Social Drinker
5.423600E-01
Non Drinker-vs-Daily Drinker
3.749200E-01
Non Drinker-vs-Weekly Drinker
9.601000E-01
Non Drinker-vs-Occasional Drinker
3.287600E-01
Non Drinker-vs-Social Drinker
7.478000E-01
Daily Drinker-vs-Weekly Drinker
4.976200E-01
Daily Drinker-vs-Occasional Drinker
1.047770E-01
Daily Drinker-vs-Social Drinker
6.350200E-01
Weekly Drinker-vs-Occasional Drinker
5.156000E-01
Weekly Drinker-vs-Social Drinker
7.859400E-01
Occasional Drinker-vs-Social Drinker
2.762400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.246800E-01
Normal-vs-Grade 2
9.502800E-01
Normal-vs-Grade 3
9.733200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.129400E-01
Grade 1-vs-Grade 3
5.071800E-01
Grade 1-vs-Grade 4
9.246800E-01
Grade 2-vs-Grade 3
5.375400E-01
Grade 2-vs-Grade 4
9.502800E-01
Grade 3-vs-Grade 4
9.733200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.711800E-01
Normal-vs-NonDiabetic
9.363600E-01
Diabetic-vs-NonDiabetic
7.786400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.407400E-01
Normal-vs-NoPancreatitis
9.150000E-01
Pancreatitis-vs-NoPancreatitis
6.887500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.823800E-01
Normal-vs-N1
8.340600E-01
N0-vs-N1
5.379200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.473600E-01
Normal-vs-TP53-NonMutant
9.736600E-01
TP53-Mutant-vs-TP53-NonMutant
7.485200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
